Combined immunotherapy for advanced prostate cancer: Empowering the T cell army.
Research output: Contribution to journal › Journal article › Communication
Standard
Combined immunotherapy for advanced prostate cancer: Empowering the T cell army. / Suleman, S; Wei, GH.
In: Asian Journal of Urology, 05.2017.Research output: Contribution to journal › Journal article › Communication
Harvard
Suleman, S & Wei, GH 2017, 'Combined immunotherapy for advanced prostate cancer: Empowering the T cell army.', Asian Journal of Urology. https://doi.org/10.1016/j.ajur.2017.04.003
APA
Suleman, S., & Wei, GH. (2017). Combined immunotherapy for advanced prostate cancer: Empowering the T cell army. Asian Journal of Urology. https://doi.org/10.1016/j.ajur.2017.04.003
Vancouver
Suleman S, Wei GH. Combined immunotherapy for advanced prostate cancer: Empowering the T cell army. Asian Journal of Urology. 2017 May. https://doi.org/10.1016/j.ajur.2017.04.003
Author
Bibtex
@article{1f4289efd4ef46e4bd70835b456e71a2,
title = "Combined immunotherapy for advanced prostate cancer: Empowering the T cell army.",
author = "S Suleman and GH Wei",
year = "2017",
month = may,
doi = "10.1016/j.ajur.2017.04.003",
language = "English",
journal = "Asian Journal of Urology",
issn = "2214-3882",
publisher = "Elsevier (Singapore) Pte Ltd",
}
RIS
TY - JOUR
T1 - Combined immunotherapy for advanced prostate cancer: Empowering the T cell army.
AU - Suleman, S
AU - Wei, GH
PY - 2017/5
Y1 - 2017/5
UR - http://europepmc.org/abstract/med/29387551
U2 - 10.1016/j.ajur.2017.04.003
DO - 10.1016/j.ajur.2017.04.003
M3 - Journal article
C2 - 29387551
JO - Asian Journal of Urology
JF - Asian Journal of Urology
SN - 2214-3882
ER -
ID: 324127110